Blisovi 24 Fe

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 18, 2025
Approval ID: 1183b048-16f3-47a4-a42f-22ba07b2bb52
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BLISOVI 24 Fe safely and effectively. See Full Prescribing Information for BLISOVI 24 Fe. Blisovi 24 Fe [norethindrone acetate and ethinyl estradiol tablets USP, (1 mg/0.02 mg) and ferrous fumarate tablets, (75 mg)] for Oral Use Initial U.S. Approval: 1968

Quick Stats

Total Products1

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.